Xijing Hospital Of Digestive Diseases
Clinical trials sponsored by Xijing Hospital Of Digestive Diseases, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Gut feeling: can a probiotic lift mood in stomach disorder? Results expected Oct 2026 (estimated)
- Gut feeling: probiotic shows promise for mood in stomach disorder Results expected Oct 2026 (estimated)
- Can a common supplement reverse stomach cancer risk? Results expected Dec 2026 (estimated)
- Can 3D vision spot hidden polyps better than standard colonoscopy? Results expected Dec 2026 (estimated)
-
New pill vs. infusion: which works better for severe colitis?
Disease control Recruiting nowThis study compares two drugs—upadacitinib (a pill) and infliximab (an infusion)—as second-line treatments for acute severe ulcerative colitis. About 226 adults will be randomly assigned to one of the two drugs for 3 months. The main goal is to see if upadacitinib can reduce symp…
Phase 4 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy offers hope for liver disease patients not helped by standard drug
Disease control Recruiting nowThis study is for adults with primary biliary cholangitis (a chronic liver disease) who also have cirrhosis and did not respond well to the usual treatment, ursodeoxycholic acid. Researchers want to see if adding fenofibrate to their treatment can improve liver health by normaliz…
Phase 2/3 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo therapy aims to tame rare liver disease
Disease control Recruiting nowThis long-term study is testing whether adding fenofibrate to standard ursodeoxycholic acid is safe for people with primary biliary cholangitis (PBC), a rare liver disease. About 300 adults who have already completed a prior fenofibrate study will take the combination and be moni…
Phase 3 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo therapy aims to tame rare liver disease in Long-Term trial
Disease control Recruiting nowThis study tests the long-term safety of combining fenofibrate with standard treatment (ursodeoxycholic acid) in 150 adults with primary biliary cholangitis, a chronic liver disease. Participants previously completed a related study and will take fenofibrate capsules daily. Resea…
Phase 3 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New combo therapy aims to help PBC patients who Don't respond to standard treatment
Disease control Recruiting nowThis Phase 3 trial tests whether adding fenofibrate to standard ursodeoxycholic acid (UDCA) therapy improves liver health in people with primary biliary cholangitis (PBC) who do not respond well to UDCA alone. About 150 adults will receive either the combination or a placebo plus…
Phase 3 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could fenofibrate be a Game-Changer for PBC patients?
Disease control Recruiting nowThis study tests whether fenofibrate, a drug used for high cholesterol, can improve liver function in adults with primary biliary cholangitis (PBC) who haven't been treated before. About 132 participants will take either fenofibrate or the standard drug UDCA for 12 months. The go…
Phase 3 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can 3D vision spot hidden polyps better than standard colonoscopy?
Diagnosis Recruiting nowThis trial tests whether a 3D imaging device used during colonoscopy helps doctors find high-risk adenomas—polyps that could turn into cancer—better than the usual 2D view. Adults aged 18-75 scheduled for a diagnostic colonoscopy will be randomly assigned to either a 2D or 3D sco…
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
New camera trick could slash stomach surgery risks
Symptom relief Recruiting nowThis study tests whether using a special imaging technique called Red Dichromatic Imaging (RDI) throughout the entire ESD procedure can reduce serious complications like bleeding and perforation, and shorten surgery time. About 640 adults with early stomach cancer or precancerous…
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Ear-Zapping device could offer Drug-Free relief for stubborn constipation
Symptom relief Recruiting nowThis trial tests whether a small device that stimulates a nerve in the ear (taVNS) can help people with constipation that hasn't improved with standard treatments. One hundred adults will be randomly assigned to receive either active or sham stimulation twice daily for 20 days. R…
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Could zapping the brain relieve stubborn constipation?
Symptom relief Recruiting nowThis study tests whether a non-invasive brain stimulation technique called tACS can help people with severe constipation that hasn't improved with standard treatments, especially when they also have stress-related physical symptoms. About 60 adults will receive either real or sha…
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Gut feeling: can a probiotic lift mood in stomach disorder?
Symptom relief Recruiting nowThis study tests whether a probiotic called Clostridium butyricum can help reduce anxiety and depression in people with functional dyspepsia (a common stomach disorder). 180 adults will receive either the probiotic or a placebo for 4 weeks, alongside standard stomach medication. …
Phase 4 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Gut feeling: probiotic shows promise for mood in stomach disorder
Symptom relief Recruiting nowThis study tests whether a probiotic called Bacillus coagulans can reduce anxiety and depression in people with functional dyspepsia, a common stomach disorder. 180 adults will receive either the probiotic or a placebo for 4 weeks, alongside standard treatment. The main goal is t…
Phase 4 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Can a simple questionnaire keep patients on track after cancer surgery?
Knowledge-focused Recruiting nowThis trial tests whether having patients complete a questionnaire about follow-up care, plus receiving feedback, can improve their adherence to scheduled endoscopic surveillance after endoscopic submucosal dissection (ESD) for early gastrointestinal growths. The study will enroll…
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC